Cargando…
The effects of l-carnitine supplementation on inflammatory factors, oxidative stress, and clinical outcomes in patients with sepsis admitted to the intensive care unit (ICU): study protocol for a double blind, randomized, placebo-controlled clinical trial
BACKGROUND: Sepsis is a common cause for admission to the intensive care unit (ICU), and its incidence has been increasing. It is associated with a significant increase in serum inflammatory biomarkers such as C-reactive protein (CRP) and cytokines such as interleukin 1 (IL-1), IL-6, and tumor necro...
Autores principales: | Keshani, Mahdi, Alikiaii, Babak, Askari, Gholamreza, Yahyapoor, Farveh, Ferns, Gordon A., Bagherniya, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861607/ https://www.ncbi.nlm.nih.gov/pubmed/35193654 http://dx.doi.org/10.1186/s13063-022-06077-3 |
Ejemplares similares
-
The effects of adjunctive treatment with l-carnitine on monitoring laboratory variables in ICU patients: a double-blinded randomized controlled clinical trial
por: Yahyapoor, Farveh, et al.
Publicado: (2023) -
The Effect of Statins on C-Reactive Protein in Stroke Patients: A Systematic Review of Clinical Trials
por: Alikiaii, Babak, et al.
Publicado: (2021) -
Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial
por: Askari, Gholamreza, et al.
Publicado: (2021) -
The prevalence and possible causes of enteral tube feeding intolerance in critically ill patients: A cross-sectional study
por: Yahyapoor, Farveh, et al.
Publicado: (2021) -
The effects of phytosomal curcumin supplementation on clinical symptoms, and inflammatory and oxidative stress biomarkers in patients with migraine: A protocol for a randomized double-blind placebo-controlled trial
por: Shojaei, Mehrnaz, et al.
Publicado: (2023)